DEMANT Demant A/S

Demant A/S: Updated financial calendar 2020

Demant A/S: Updated financial calendar 2020

Company announcement no 2020-1125 September 2020

Change of date of publication of Interim Management Statement

The date of publication of Demant’s Interim Management Statement has been changed from

3 November to 13 October 2020.

29 September to 12 October 2020Quiet period prior to publication of Interim Management Statement
13 October 2020Interim Management Statement

* * * * * * *

Further information:

Mathias Holten Sørensen, Head of Investor Relations

Christian Lange, Investor Relations Officer

Phone

 

Attachment

EN
25/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Demant A/S

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Rune Majlund Dahl
  • Rune Majlund Dahl

Demant (Buy, TP: DKK300.00) - Headwinds set to persist in Q1

We forecast Q1 organic sales growth of just 0.6% YOY, below the full-year guidance, owing to persistent headwinds in wholesale. However, with Managed Care headwinds set to annualise from Q2, better quarters should lie ahead. We expect an unchanged 2025 guidance of 3–7% organic sales growth and DKK4.5bn–4.9bn in EBIT, but we find the lower end most likely. We reiterate our BUY but have cut our target price to DKK300 (320).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch